Xeris Pharmaceuticals | Betriebsaufwand



Operating Expenses Veränderung Datum
Adcock Ingram Holdings ZAR 4.42B 268.95M 2024-06
Celltrion KRW 674.25B 128.01B 2024-09
Cspc Pharmaceutical CNY 5.42B 102.74M 2024-09
Dianthus Therapeutics USD 33.24M 1.17M 2024-12
Ecofibre AUD 12.31M 44.07M 2024-06
Eli Lilly USD 8.38B 1.53B 2024-12
Kangmei Pharma CNY 1.46B 193.63M 2024-09
Knight Therapeutics CAD 89.06M 2.02M 2024-09
Laboratorios Farma EUR 311.35M 170.35M 2024-12
Malin Corporation EUR 700K 1.6M 2024-06
Medical Developments International AUD 10.35M 17.73M 2024-06
Neuren Pharmaceuticals AUD 17.41M 2.86M 2024-12
Organigram Holdings CAD 54.04M 9.62M 2024-12
Pacira USD 162.55M 145.55M 2024-12
Perrigo USD 1.03B 13.4M 2024-12
Pharma Mar EUR 43.47M 3.3M 2024-12
Qiagen NV USD 377.04M 4.6M 2024-12
Sartorius EUR 725.4M 29M 2024-09
Sino Biopharmaceutical CNY 11.66B 5.46B 2024-12
Supernus Pharmaceuticals USD 152.75M 17.91M 2024-12
Tilray USD 253.17M 16.55M 2024-11
Zz Pientze Pharmaceu 1.67B 86.7M 2024-09



Xeris Pharmaceuticals Betriebsaufwand - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Apr 2025.